Everything You Want to Know About PARP Inhibitors

The Role of PARP Inhibitors in Advanced Prostate CancerПодробнее

Everything You Need to Know About ICIs in Gynecologic CancersПодробнее

Addressing Current Questions and Controversies in the Management of Prostate CancerПодробнее

Improving Interprofessional Management and Clinical Outcomes with PARP Inhibitors for Advanced Ov...Подробнее

Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combination...Подробнее

Episode 227: Biomarker Testing, PARP Inhibitors, and Oral Adherence During Ovarian Cancer Mainten...Подробнее

Episode 232: Managing Fatigue During PARP Inhibitor Maintenance TherapyПодробнее

Integrating New Research Information into Current Clinical Care — Ovarian CancerПодробнее

Advancing Therapeutic Paradigms for Ovarian Cancer in The Era of PARP Inhibitors: A Guide for The...Подробнее

Advanced Prostate Cancer: What You Need to Know About Evolving Treatment and ResearchПодробнее

New FDA Approved PARP Inhibitor: Talzenna (Talazoparib) & Xtandi | #markscholzmd #AlexScholz #pcriПодробнее

Round-table discussion on PARP inhibitorПодробнее

Things you should know about Lynparza, the New Pancreatic Cancer DrugПодробнее

Prostate Cancer: What You Need to KnowПодробнее

What’s New with PARP Inhibitors and Ovarian Cancer?Подробнее

Navigating PARP Inhibitors: A Nurse's View - Valerie BoweringПодробнее

Webinar: Parp-Inhibitors and Prostate Cancer - Gotta Have a Mutation??? 06/29/2023Подробнее

PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test (2023)Подробнее

PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023Подробнее

The Role of PARP Inhibitors in Advanced Prostate Cancer (2023)Подробнее